CompositionTrivolib 1 Tablet is a combination anti-diabetic medicine used in adults to treat type 2 diabetes mellitus when single or dual medicines do not provide adequate blood sugar control. Maintaining good blood sugar levels helps lower the risk of long-term diabetes complications such as kidney damage, nerve problems, vision loss, and cardiovascular events.
It contains three active medicines: glimepiride, metformin, and voglibose. Glimepiride stimulates the pancreas to release more insulin; metformin reduces glucose production in the liver and improves insulin sensitivity; and voglibose delays carbohydrate breakdown in the intestine, preventing sharp post-meal blood sugar spikes.
Take this tablet exactly as prescribed by your doctor, usually with or just before your first main meal. Swallow the extended-release tablet whole with water without crushing, chewing, or breaking it. Do not skip meals while taking this medicine to avoid low blood sugar (hypoglycaemia).
Adopting a balanced diabetic diet, engaging in regular physical activity, monitoring blood glucose levels, and maintaining a healthy weight are essential parts of your overall diabetes management.
Tell your doctor if you have liver or kidney disease, heart failure, or severe infection before taking this medicine. Regularly check your blood sugar and inform your doctor if you experience symptoms of low blood sugar, such as sweating, shakiness, fast heart rate, or dizziness.
